About Odyssey Therapeutics
Odyssey Therapeutics is a biotechnology company pioneering the efficient development of next-generation immunomodulators and oncology medicines. Odyssey is making a transformational impact on the field of drug discovery and is accelerating the path to clinical development to drive the creation of more effective precision medicines. The company's integrated drug-hunting engine is designed to accelerate drug discovery by unlocking targets with great potential and minimizing attrition.
Open positions (1)
Company details
Funding
Total raised
$700M
Last stage
Public
Investors
Founders
Gary D. Glick
Serial biotech entrepreneur and chemist; previously founded Lycera Corporation, co-founded IFM Therapeutics and Scorpion Therapeutics; former emeritus professor of chemistry at the University of Michigan.
LinkedInDavid Pompliano
Co-founder of Odyssey Therapeutics, serving as Chief Innovation Officer.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.